Ignite Creation Date:
2025-12-25 @ 4:02 AM
Ignite Modification Date:
2026-05-01 @ 11:04 PM
Study NCT ID:
NCT04419402
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2024-02-07
First Post:
2020-05-28
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Enzalutamide With Lu PSMA-617 Versus Enzalutamide Alone in Men With Metastatic Castration-resistant Prostate Cancer
Sponsor:
Australian and New Zealand Urogenital and Prostate Cancer Trials Group
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
ANZUP 1901
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None